ADA 2009 Recommendations Reaffirm Acceptance of Low Carb Diet Diabetes Health (press release), CA - How a patient moves from metformin to a sulfonylurea or combination product and then on to Januvia , Byetta, or insulin is left up to the medical ... Know You Numbers, Outlive Your Diabetes author interview (part 3)

FDA Roundup: Drugs for Depression, Diabetes and Psoriasis Wall Street Journal Blogs, NY - By that time, the company hopes to have another diabetes medicine on the market: alogliptin, in the same class as Mercks Januvia . ...

Takeda: US FDA to respond on diabetes drug by June Reuters - ID:nT177998 Alogliptin belongs to a new class of diabetes drugs called DPP-4 inhibitors, and Takeda hopes it will compete with rival drug Januvia from ...

Slim pickings among obesity drugs Bizjournals.com, NC - The study predicts Merck (NYSE: MRK) will become a top metabolism drug marketer in four or five years when it releases Januvia . The study notes, however, ... Novo Nordisk Will Remain the Dominant Player in the Metabolic Drug ... Decision Resources: Obesity market seeking drug developers

Times of Malta New pill for injection-free diabetes Times of Malta, Malta - A new class of medicines, like Januvia , add an important arsenal in the fight against diabetes, says consultant endocrinologist Michael Zouvanis. ...

Amylin Gets Some FDA Love Motley Fool - ... diabetes medications like Merck's (NYSE: MRK) Januvia and GlaxoSmithKline's (NYSE: GSK) Avandia, Amylin really needs the once-weekly version approved. ...

The Promotional Landscape in US and Europe - Benchmarking ... Live-PR.com (Pressemitteilung), Austria - This was largely due to new product launches, such as the vaccine Gardasil and diabetes treatment Januvia . Eli Lilly and Novartis were the next largest ...

Amylin shares rise on prospects for exenatide LAR Forbes, NY - Meanwhile, Merck & Co. already markets the diabetes treatment Januvia , while Bristol-Myers Squibb Co. and AstraZeneca are developing saxagliptin. ...

FDA Dashes Amylin Investors' Hopes Motley Fool - After all, there are so many effective oral drugs available -- like Merck's (NYSE: MRK) Januvia , Takeda's Actos, and metformin, the long-genericized version ...

Merck Outlines Long-Term Prospects and Progress on Strategic Plan ... MarketWatch - For JANUVIA and ISENTRESS, for example, we are developing fixed dose combinations to enable these medicines to become cornerstones of treatment. ... Ahead of the Bell: Merck to update on research